新生儿低血糖与学龄期神经认知功能:前瞻性队列研究
pre-hPOD 研究纳入至少 1 个新生儿低血糖危险因素的儿童,在纠正年龄 6–7 岁时评估神经认知功能;低血糖暴露组与非暴露组的神经认知损害比例相似(51% vs 50%,aRD -4%,95%CI -15%~7%),但严重或复发性低血糖与视觉运动感知较差及情绪行为困难风险增加相关。
要点
- 新生儿低血糖暴露未增加学龄期神经认知损害风险(51% vs 50%,aRD -4%,95%CI -15%~7%)。
- 严重或复发性低血糖与视觉运动感知较差及情绪行为困难风险增加相关。
- 低血糖定义:连续血糖 <47 mg/dl(2.6 mmol/L);严重 <36 mg/dl(2.0 mmol/L)。
核心结论
- 在有低血糖危险因素的新生儿中,新生儿低血糖暴露与学龄期神经认知损害风险无显著关联。
- 严重或复发性低血糖发作可能对视觉运动感知和情绪行为有不良影响。
研究设计与样本
- pre-hPOD 研究为前瞻性队列研究,纳入至少 1 个新生儿低血糖危险因素的儿童。
- 在纠正年龄 6–7 岁时评估认知与运动功能(NIH-Toolbox)、学习、视觉感知和行为。
- 392 名合格儿童中 315 名(80%)完成学龄期评估,主要结局分析 n=308;47% 经历过低血糖。
主要发现
- 神经认知损害在低血糖组与非低血糖组相似(51% vs 50%;aRD -4%,95%CI -15%~7%)。
- 严重或复发性低血糖儿童视觉运动感知更差,情绪行为困难风险增加。
- 分析调整了胎龄、出生体重、性别和预防性葡萄糖凝胶(pre-hPOD 干预)等混杂因素。
关键数值与推荐
- 低血糖定义为连续血糖浓度 <47 mg/dl(2.6 mmol/L)至少 1 次。
- 严重低血糖定义为 <36 mg/dl(2.0 mmol/L);轻度定义为 36 至 <47 mg/dL(2.0 至 <2.6 mmol/L)。
- 短暂低血糖定义为 1–2 次发作;复发性低血糖定义为 ≥3 次发作。
- 主要结局神经认知损害定义为 NIH-Toolbox 测试中 ≥1 项低于常模均值 >1 SD。
临床怎么用
- 对有低血糖危险因素的新生儿,应关注严重或复发性低血糖发作的潜在长期影响。
- 学龄期随访可关注视觉运动感知和情绪行为问题,尤其是曾发生严重或复发性低血糖的儿童。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the relationship between transient neonatal hypoglycemia in at-risk infants and neurocognitive function at 6-7 years of corrected age. STUDY DESIGN: The pre-hPOD Study involved children born with at least 1 risk factor for neonatal hypoglycemia. Hypoglycemia was defined as ≥1 consecutive blood glucose concentrations <47 mg/dl (2.6 mmol/L), severe as <36 mg/dl (2.0 mmol/L), mild as 36 to <47 mg/dL (2.0 to <2.6 mmol/L), brief as 1-2 episodes, and recurrent as ≥3 episodes. At 6-7 years children were assessed for cognitive and motor function (NIH-Toolbox), learning, visual perception and behavior. The primary outcome was neurocognitive impairment, defined as >1 SD below the normative mean in ≥1 Toolbox tests. The 8 secondary outcomes covered children's cognitive, motor, language, emotional-behavioral, and visual perceptual development. Primary and secondary outcomes were compared between children who did and did not experience neonatal hypoglycemia, adjusting for potential confounding by gestation, birthweight, sex and receipt of prophylactic dextrose gel (pre-hPOD intervention). Secondary analysis included assessment by severity and frequency of hypoglycemia. RESULTS: Of 392 eligible children, 315 (80%) were assessed at school age (primary outcome, n = 308); 47% experienced hypoglycemia. Neurocognitive impairment was similar between exposure groups (hypoglycemia 51% vs 50% no hypoglycemia; aRD -4%, 95% CI -15%, 7%). Children with severe or recurrent hypoglycemia had worse visual motion perception and increased risk of emotional-behavioral difficulty. CONCLUSION: Exposure to neonatal hypoglycemia was not associated with risk of neurocognitive impairment at school-age in at-risk infants, but severe and recurrent episodes may have adverse impacts. TRIAL REGISTRATION: Hypoglycemia Prevention in Newborns with Oral Dextrose: the Dosage Trial (pre-hPOD Study): ACTRN12613000322730.
引用
- Wei X, Franke N, Alsweiler JM, et al. Neonatal Hypoglycemia and Neurocognitive Function at School Age: A Prospective Cohort Study. J Pediatr. 2024. PMID: 38815750. doi:10.1016/j.jpeds.2024.114119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。